arrow
M

Michael D. Keller

children's national hospital and george washington university
H指数:33
被引数:7,886

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Third-Party Viral Specific T cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT

第三方病毒特异性T细胞用于免疫缺陷宿主及准入障碍:ASTCT专家小组的综述与评论

2026-05-020
PRE
Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report

造血细胞移植治疗Wiskott-Aldrich综合征:一份PIDTC报告

2025-12-080
OAAI
Outcomes Following Matched Sibling Donor Transplantation for Severe Combined Immunodeficiency: A Report from the PIDTC

严重联合免疫缺陷病接受同胞供体移植后的结局:PIDTC的报告

2025-11-270
OAAI
Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function

出版更正:TCF1和LEF1促进B-1a细胞的稳态和调控功能

Nature
IF48.5
2025-09-160
OAAI
TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function

TCF1和LEF1促进B-1a细胞的稳态和调控功能

Nature
IF48.5
2025-08-200
OA
Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study

靶向保守表位的自体HIV特异性T细胞疗法在6名HIV感染者中的耐受性良好:一项开放标签、单臂的1期研究

2025-05-150
OA
T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy

T细胞对流感疫苗接种的免疫反应:在自体嵌合抗原受体修饰T细胞治疗前后给药

2025-05-011
PRE
Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy

多中心研究:接受酶替代疗法治疗的腺苷脱氨酶严重联合免疫缺陷(ADA-SCID)患者中elapegademase治疗的多年登记研究

2025-03-270
OA
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature

多组学分析揭示人类RAG缺陷症表现出独特的免疫失调模式,但具有共同的炎症特征

2025-01-010
OA
Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant
2024-09-011
PRE
Reconstitution of Norovirus-Specific T-Cell Responses Following Hematopoietic Stem Cell Transplantation in Patients With Inborn Errors of Immunity and Chronic Norovirus Infection
2024-08-140
PRE
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
2024-04-183
OAAI
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication
2024-03-292
OAAI
Human PLCG2 haploinsufficiency results in a nowel natural killer cell immunodeficiency

人类PLCG2单倍不足导致nowel自然杀伤细胞免疫缺陷

2024-01-015
PRE
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune DeficiencyTreatment Consortium
LANCET
IF88.5
2023-07-0130
OAAI